Browsing Tag
cytarabine
2 posts
Moleculin’s $9.3m raise adds 49.5m potential shares after MIRACLE update
Moleculin’s 37% MIRACLE remission signal is followed by a $9.3 million offering, heavy warrant dilution and a 59% stock drop.
Can Moleculin’s MIRACLE trial redefine AML treatment? Company to showcase study at leukemia event
Find out how Moleculin’s MIRACLE phase 3 trial could reshape AML treatment as the company presents its latest progress at the Madrid leukemia meeting.